Double Recombinant Vaccinia Virus: A Candidate Drug against Human Glioblastoma

Double Recombinant Vaccinia Virus: A Candidate Drug against Human Glioblastoma

Glioblastoma is one of the most aggressive brain tumors. Given the poor prognosis of this disease, novel methods for glioblastoma treatment are needed. Virotherapy is one of the most actively developed approaches for cancer therapy today. VV-GMCSF-Lact is a recombinant vaccinia virus with deletions...

Full description

Bibliographic Details
Main Authors: Natalia Vasileva, Alisa Ageenko, Maria Dmitrieva, Anna Nushtaeva, Sergey Mishinov, Galina Kochneva, Vladimir Richter, Elena Kuligina
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Life
Subjects:
glioblastoma
oncolytic virus
VV-GMCSF-Lact
glioma stem cells
patient-derived glioblastoma cultures
Online Access:https://www.mdpi.com/2075-1729/11/10/1084

Similar Items

Similar Items